Antipsychotics in individuals with intellectual disability

Lancet. 2008 May 3;371(9623):1501; author reply 1502. doi: 10.1016/S0140-6736(08)60646-7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / therapeutic use*
  • Behavior Control / methods*
  • Haloperidol / administration & dosage
  • Haloperidol / therapeutic use
  • Humans
  • Intellectual Disability
  • Randomized Controlled Trials as Topic
  • Risperidone / administration & dosage
  • Risperidone / therapeutic use

Substances

  • Antipsychotic Agents
  • Haloperidol
  • Risperidone